https://clinicaltrials.gov/ct2/show/NCT03935334?type=Intr&cond=hemophilia&lupd_s=04%2F18%2F2019&lupd_d=14
Condition : Hemophilia A or B With Inhibitor
Interventions : Biological: Biosimilar eptacog alfa, activated (AryoSeven); Biological: Eptacog alfa, activated (Novoseven)
Sponsor : AryoGen Pharmed Co.
Recruiting
Clinical Trial Comparing a Biosimilar Eptacog Alfa With Novoseven, in Patients With Hemophilia With Inhibitors
NCT03935334
Thu, 02 May 2019 12:00:00 EDT
Last Update Posted: 05/02/19 07:49AM
